DCM
AMED

Dupont Capital Management’s Amedisys AMED Stock Holding History

Dupont Capital Management’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-1,462
Closed -$142K – 1433
2022
Q3 		$142K Sell
1,462
-1,282
-47% -$153K 0.01% 944
2022
Q2 		$288K Sell
2,744
-1,953
-42% -$250K 0.01% 868
2022
Q1 		$809K Buy
4,697
+1,799
+62% +$269K 0.03% 586
2021
Q4 		$469K Sell
2,898
-4,280
-60% -$688K 0.02% 835
2021
Q3 		$1.07M Buy
7,178
+3,995
+126% +$830K 0.03% 510
2021
Q2 		$780K Buy
+3,183
New +$835K 0.02% 739
2021
Q1 		– Sell
-6,284
Closed -$1.84M – 1576
2020
Q4 		$1.84M Sell
6,284
-186
-3% -$47.7K 0.04% 359
2020
Q3 		$1.53M Sell
6,470
-61
-0.9% -$13.9K 0.03% 364
2020
Q2 		$1.3M Sell
6,531
-2,852
-30% -$532K 0.03% 426
2020
Q1 		$1.72M Sell
9,383
-3,529
-27% -$628K 0.04% 327
2019
Q4 		$2.15M Sell
12,912
-10,220
-44% -$1.52M 0.05% 337
2019
Q3 		$3.03M Sell
23,132
-14,400
-38% -$1.87M 0.07% 252
2019
Q2 		$4.56M Buy
37,532
+3,626
+11% +$430K 0.1% 188
2019
Q1 		$4.18M Buy
33,906
+9,464
+39% +$1.19M 0.1% 203
2018
Q4 		$2.86M Buy
24,442
+18,700
+326% +$2.2M 0.07% 275
2018
Q3 		$718K Buy
+5,742
New +$634K 0.02% 646

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Mackenzie Financial
Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Dupont Capital Management's AMED Position: Q4 2022 in Review

Dupont Capital Management sold out of Amedisys (AMED) in Q4 2022, closing a stake of 1,462 shares — an estimated $142K sold.

Dupont Capital Management first reported a position in AMED in Q3 2018 and held it in 16 quarters. The position peaked at $4.56M in Q2 2019. 277 funds tracked by Wall St. Rank hold AMED as of Q4 2022.

  • Dupont Capital Management reported no remaining Amedisys position as of Q4 2022 after selling out during the quarter.
  • Dupont Capital Management sold 1,462 Amedisys shares in Q4 2022, an estimated $142K.
  • Dupont Capital Management first reported a position in Amedisys in Q3 2018 and held it in 16 quarters.
  • Dupont Capital Management's Amedisys position peaked at $4.56M in Q2 2019.
  • 277 funds tracked by Wall St. Rank held Amedisys as of Q4 2022.

Based on Dupont Capital Management's 13F filing for Q4 2022, filed 26 Jan 2023.